United States· US:84803-104_5a0e9ed0-8900-f1b7-e063-6394a90abe9f
Ultra Violette Sheen Screen Broad Spectrum Hydrating Lip Balm Dusk
A medicinal product containing octinoxate; avobenzone; octocrylene, registered in United States by Grace And Fire USA Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- OCTINOXATE; AVOBENZONE; OCTOCRYLENE
- Manufacturer
- Grace And Fire USA Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1184803-104-01
- ndc1184803-104-02
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Octinoxate; avobenzone; octocrylene in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b4018895-4df3-46ff-bbb4-0276a8362648 GET /v1/drugs/b4018895-4df3-46ff-bbb4-0276a8362648?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "5; 3; 4.7",
"substance": "OCTINOXATE; AVOBENZONE; OCTOCRYLENE",
"productndc": "84803-104",
"dosage_form": "OINTMENT",
"dea_schedule": null,
"strength_unit": "g/100g; g/100g; g/100g",
"application_number": "M020",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about octinoxate; avobenzone; octocrylene.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.